Results 141 to 150 of about 3,120 (153)

Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia. [PDF]

open access: yesLeukemia
Sharman JP   +26 more
europepmc   +1 more source

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial. [PDF]

open access: yesJ Clin Oncol
Mohty M   +19 more
europepmc   +1 more source

Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie

open access: green, 2011
P.M. Schmidt   +5 more
openalex   +1 more source

A longitudinal study of right ventricular function of patients with multiple myeloma treated with carfilzomib. [PDF]

open access: yesERJ Open Res
Basin S   +10 more
europepmc   +1 more source

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients. [PDF]

open access: yesAnn Hematol
Osanno L   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy